✦ LIBER ✦

Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer

✍ Scribed by Kenichi Sakurai; Katsuhisa Enomoto; Sadao Amano

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 235 KB
Volume: 137
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-010-0894-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 randomized trial of primary endo

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/

Long-term survival of resectable subset

Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer

✍ Yo-Han Cho; Se Hoon Lee; Dong-Wan Kim; Hong-Gyun Wu; J. Hun Hah; Chae-Seo Rhee; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

## Abstract ## Background. Although meta‐analysis showed that survival improved with concurrent chemoradiation in locally advanced head and neck cancer, neoadjuvant chemotherapy is still unique, because it renders curative surgery feasible for marginally resectable head and neck cancer patients.

Incidence of chemotherapy-induced, long-

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

✍ Monica N. Fornier; Shanu Modi; Katherine S. Panageas; Larry Norton; Clifford Hud 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Disease-free interval and estrogen recep

Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up

✍ J. M. M. Raemaekers; L. V. A. M. Beex; A. J. M. Koenders; G. F. F. M. Pieters; A 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 535 KB

Sustained long-term hematologic recovery

Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy

✍ J.P. Maciejewski; S. Kim; E. Sloand; C. Selleri; N.S. Young 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Previously, we reported that patients with aplastic anemia (AA) have profoundly decreased numbers of hematopoietic progenitor and stem cells as measured in the longterm culture initiating cell (LTC-IC) assay (Blood 1996;88:1983-1991). We now present results of a long-term prospective study of LTC-IC

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views